 |
|
The impact of tobacco smoking on treatment choice and efficacy in inflammatory bowel disease
Steven Nicolaides, Abhinav Vasudevan, Tony Long, Daniel van Langenberg
Intest Res. 2021;19(2):158-170. Published online 2020 Oct 13 DOI: https://doi.org/10.5217/ir.2020.00008
|
|
Citations to this article as recorded by
 Defining the Roles of Inflammatory Bowel Disease Clinical Pharmacists in the United States: A Systematic Review and National RAND/UCLA Consensus
Shubha Bhat, Ruishen Lyu, Mitali Agarwal, Michelle Becker, Richard Bloomfeld, David H Bruining, Benjamin L Cohen, Marina Ivanov, Jonathan A Leighton, Alyssa P Stewart, Lindsay Trocke, Stacy S Tse, Ryan C Ungaro, Byron P Vaughn, Miguel Regueiro, Erick Sokn
Inflammatory Bowel Diseases.2024; 30(6): 950. CrossRef Duration of smoking cessation in patients with inflammatory bowel disease
Carlos González-Muñoza, Cristina Gely, Jordi Gordillo, Federico Bertoletti, Antonio Giordano, Alberto López-Faba, Esther García-Planella
Gastroenterología y Hepatología.2024; 47(6): 591. CrossRef Role of Environmental Risk Factors in the Etiology of Inflammatory Bowel Diseases: A Multicenter Study
Cemile Cansu Alperen, Barıs Soydas, Ender Serin, Mustafa Erbayrak, Nurten Akyurek Savas, Gulhan Kanat Unler, Cenk Emre Meral, Ugur Toprak, Ahmet Sedat Boyacioglu, Ulku Dagli
Digestive Diseases and Sciences.2024;[Epub] CrossRef Need for therapeutic escalation in patients with refractory ulcerative proctitis: Results from the PROCU study of the ENEIDA registry
Rocío Ferreiro‐Iglesias, Sol Porto Silva, Sandra Marín, María José Casanova, Míriam Mañosa, Carlos González‐Muñoza, Ruth de Francisco, Berta Caballol, Lara Arias, Marta Piqueras, Yamile Zabana, Montserrat Rivero, Xavier Calvet, Francisco Mesonero, Pilar V
Alimentary Pharmacology & Therapeutics.2024;[Epub] CrossRef Akkermansia muciniphila and Parabacteroides distasonis as prognostic markers for relapse in ulcerative colitis patients
Ana Mendes-Frias, Marta Moreira, Maria C. Vieira, Joana Gaifem, Patrício Costa, Luís Lopes, Ricardo Silvestre
Frontiers in Cellular and Infection Microbiology.2024;[Epub] CrossRef DAMP-ing IBD: Extinguish the Fire and Prevent Smoldering
Oliver Sandys, Pieter C. F. Stokkers, Anje A. te Velde
Digestive Diseases and Sciences.2024;[Epub] CrossRef Duration of smoking cessation in patients with inflammatory bowel disease
Carlos González-Muñoza, Cristina Gely, Jordi Gordillo, Federico Bertoletti, Antonio Giordano, Alberto López-Faba, Esther García-Planella
Gastroenterología y Hepatología (English Edition).2024; 47(6): 591. CrossRef Tobacco use in Crohn's disease patients and association with disease outcomes in the United States Medicaid population, 2010–2019
Ryan A. Jasper, Po‐Hung Chen, Reeha Patel, Shelly Joseph, Steven D. Miller, Susan Hutfless
JGH Open.2023; 7(4): 291. CrossRef Inflammatory Bowel Disease: Pathophysiology, Treatment, and Disease Modeling
Jiryeon Jang, Sehoon Jeong
BioChip Journal.2023; 17(4): 403. CrossRef High-Dimensional DNA Methylation Mediates the Effect of Smoking on Crohn’s Disease
Tingting Wang, Pingtian Xia, Ping Su
Frontiers in Genetics.2022;[Epub] CrossRef Inflammatory bowel disease in Korea: epidemiology and pathophysiology
Jung Won Lee, Chang Soo Eun
The Korean Journal of Internal Medicine.2022; 37(5): 885. CrossRef Clinical profile, course and outcomes of adults with inflammatory bowel disease over a decade: a single center experience
Reham Saleh Aljohani, Ali Alaklabi, Yumna Mohammed Alsitary, Majd Abdulrahman bin Khunayn, Shahd Omar Hijazi, Rema Ibraheem Alshagary, Rajkumar Rajendram
Annals of Saudi Medicine.2022; 42(6): 397. CrossRef
|